Insight Molecular Diagnostics Inc. (IMDX)

NASDAQ

$3,17

$-0,21

(-6,23%)

Pre-Market

Insight Molecular Diagnostics Inc. (IMDX) Live Price Chart

Last updated: ⁦2026-10-13 10:27:00⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Insight Molecular Diagnostics Inc. (IMDX) operates in the IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES sector and is listed on NASDAQ. The stock is currently priced at $3,17, with a market capitalisation of $110,28M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2,42 to $8,51. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$110,28M
Open	$3,35
Day's High	$8,51
Day's Low	$2,33
Previous Close	$3,37
Volume	212,32K
Average Volume	222,70K
P/E Ratio	--
52-Week High	$8,51
52-Week Low	$2,42
Dividend Yield	--
Earnings Date	--

Insight Molecular Diagnostics Inc. (IMDX) Pre-Market Stock Price

Insight Molecular Diagnostics Inc. (IMDX) is trading at $3,46 in pre-market trading as of 2026-10-12 23:31:00, up 2,67% ($0,09) from the previous close of $3,37

Pre-market trading shows how investors are pricing IMDX before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.

Insight Molecular Diagnostics Inc. (IMDX) 7-Day Stock Price Change

Over the past seven days, Insight Molecular Diagnostics Inc. (IMDX) moved from $3,44 to $3,17, representing a decline of 7,85% ($0,27).

The stock traded between $3,08 and $3,76 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 289,79 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

IMDX 52-Week Price Position

Position in Range: 12,3%

52W Low$2,42

52W High$8,51

IMDX is currently trading at $3,17, placing it 12,3% of the way from its 52-week low of $2,42 to its 52-week high of $8,51. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Insight Molecular Diagnostics Inc. (IMDX)?

Insight Molecular Diagnostics Inc is a pioneering diagnostics technology company whose mission is to democratize access to novel molecular diagnostic testing to improve patient outcomes. The Company's flagship technology quantifies a molecular biomarker known as donor-derived cell-free DNA (dd-cfDNA). It is also in the process of rebranding its RUO test kit, GraftAssure, as GraftAssureIQ, and rebranding its future in-vitro diagnostic (IVD) test kit as GraftAssureDx. The company geographically operates in the United States, the United Kingdom, Europe, and the Asia-Pacific regions, with maximum revenue generated from the USA.

Insight Molecular Diagnostics Inc. Information

Industry	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Employees	58
Exchange	NASDAQ
Company Website	https://www.imdxinc.com

How to Buy Insight Molecular Diagnostics Inc. (IMDX) Stock on MEXC

Eligible investors can buy real shares of Insight Molecular Diagnostics Inc. (IMDX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for IMDX and Place Your Order

Open the RealStocks trading page and search for IMDX. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Insight Molecular Diagnostics Inc. (IMDX) stock price today?

Insight Molecular Diagnostics Inc. (IMDX) is currently trading at $ 3,17, down 5,93% ($0,20) from the previous close of $ 3,37. Intraday prices update in real time during regular trading hours.

2.Is IMDX stock going up or down today?

As of 2026-10-12 23:31:00, IMDX is trading at $ 3,17, down 5,93% ($0,20) from its previous close of $ 3,37. The stock has traded between $ 2,33 and $ 8,51 during today’s regular session. Past price movements do not guarantee future results.

3.What is IMDX pre-market price?

As of 2026-10-12 23:31:00, IMDX is trading at $ 3,46 in pre-market trading, up 2,67% ($0,09) from the previous close of $ 3,37. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is IMDX after-hours price?

As of 2026-10-12 23:31:00, IMDX is trading at $ 3,20 in after-hours trading, down 5,04% ($0,17) from the regular-session close of $ 3,37. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is IMDX stock trading now?

IMDX trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does IMDX sit relative to its 52-week high and low?

Over the past 52 weeks, IMDX has traded between a low of $ 2,42 and a high of $ 8,51. At $ 3,17, the stock is positioned 12,3% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Insight Molecular Diagnostics Inc. in?

Insight Molecular Diagnostics Inc. (IMDX) operates in the IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Insight Molecular Diagnostics Inc.'s market capitalisation and where is it listed?

Insight Molecular Diagnostics Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 110,28M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is IMDX valued in terms of P/E ratio and EPS?

IMDX trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -1,51. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Insight Molecular Diagnostics Inc. pay a dividend?

Insight Molecular Diagnostics Inc. pays an indicated annual cash dividend of $ 0,00 per share, with a current dividend yield of 0,00% based on the latest share price. Dividend policies are subject to change at the board's discretion.